S. Korea Frees Extra $100 Million To Double Tamiflu Supply
This article was originally published in PharmAsia News
Executive Summary
South Korea President Lee Myung-bak has authorized emergency funds from the treasury to deal with what is expected to become a serious epidemic in October or November. At a meeting with his chief secretaries, the release of the funds would allow the government to double its current supply of 5.3 million doses of Roche's Tamiflu (oseltamivir). Separately, officials allocated a $100 million increase in the government budget for antiviral purchases. (Click here for more
You may also be interested in...
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.